USPTO serial 77320652
SANTHERA PHARMACEUTICALS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BROWNE, DAYNA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SANTHERA PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Concannon
PATRICK CONCANNON EDWARDS ANDELL PALMER & DODGE LLP111 HUNTINGTON AVENUEBOSTON, MA 02199UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular and metabolic system including diabetes, the respiratory system, musculoskeletal and inflammatory disorders, or for use in dermatology, oncology, hematology, ophthalmology, in transplantation; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for the treatment of bone, endocrinological, circulatory, hormonal and rheumatic disorders; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for use in gastro-enterology, for the prevention and treatment of ocular disorders; anti-infectives, anti-bacterials, antivirals, antibiotics, anti-fungals, vaccines, but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for diagnostic purposes, namely, diagnostic preparations for medical purposes; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gebrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; but not for use in the fields of onlcology or rheumatoid arthritis; reagents for medical use; biological preparations for medical purposes but not for use in the fields of onlcology or rheumatoid arthritis; diagnostic agents, preparations and substances for medical purposes | ACTIVE | — |
| 009 | Scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, computer hardware and software, for use with medical patient monitoring equipment, for measuring, receiving, processing, transmitting and displaying data; scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, computers, gamma cameras, collimators, aperture plates and computer software, all sold together as a unit for use in measuring the physical and mental condition of individuals affected by ataxia, muscular dystrophies, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use | ACTIVE | — |
| 010 | Surgical and medical apparatus and instruments for use in general surgery | ACTIVE | — |
| 016 | Printed informational cards in the field of pharmaceuticals; printed publications, namely, newsletters, case studies, and white papers in the fields of pharmaceuticals, central nervous system-related conditions, ophthalmological diseases, and neuromuscular diseases | ACTIVE | — |
| 042 | Pharmaceutical research and development services; chemical analysis for the pharmaceutical industry; scientific research and development; scientific research, namely, conducting clinical trials; providing scientific research information in the field of pharmaceuticals and clinical trials | ACTIVE | — |
| 044 | Hygienic and beauty care for human beings or animals, namely, providing health, medical and pharmaceutical information, consultancy and advisory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Santhera Pharmaceuticals Holding AG
- Other trademarks owned by Santhera Pharmaceuticals Holding AG
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SANTHERA PHARMACEUTICALS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 9, 2013 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 9, 2013 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 9, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| May 25, 2013 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 24, 2013 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 24, 2013 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 29, 2013 | EXT5 | SOU EXTENSION 5 FILED | — |
| Apr 29, 2013 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 31, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 30, 2012 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 25, 2012 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 25, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 3, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 2, 2012 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 25, 2012 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 25, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 3, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 2, 2011 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 1, 2011 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 31, 2011 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 31, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 14, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 12, 2011 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 12, 2011 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 12, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 2, 2010 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 17, 2010 | PAPER RECEIVED | — | |
| Sep 17, 2010 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Sep 17, 2010 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Sep 17, 2010 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| May 19, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 13, 2010 | PAPER RECEIVED | — | |
| Apr 27, 2009 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Dec 19, 2008 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 16, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 26, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 10, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 6, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 31, 2008 | DMCC | DATA MODIFICATION COMPLETED | — |
| Oct 15, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 12, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 2, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 29, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 25, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 25, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 12, 2008 | PAPER RECEIVED | — | |
| Feb 19, 2008 | CEPE | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | — |
| Feb 15, 2008 | ALIE | ASSIGNED TO LIE | — |
| Feb 15, 2008 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Feb 15, 2008 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Feb 15, 2008 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Feb 14, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 8, 2007 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Nov 7, 2007 | NWAP | NEW APPLICATION ENTERED | — |